Governor Pat McCrory, North Carolina Commerce Secretary John E. Skvarla, III, and the Economic Development Partnership of North Carolina (EDPNC) announced that an expansion by Aurobindo Pharma USA, Inc. will bring 275 new R&D and pharma-manufacturing jobs to Durham. The New Jersey-based maker of generic pharmaceuticals plans to invest over $31.7 million in a new state-of-the-art national headquarters for specialty pharmaceutical R&D.  “Our state is eager topartner with this global company as it embarks on its business objectives and grows its presence in North Carolina’s life sciences community,” said Governor McCrory.  Aurobindo Pharma USA will establish a new R&D and manufacturing center in Durham. The company currently employs 14 scientists/workers in Raleigh. Among the new employees will be researchers, analytical chemists, production operators, quality control specialists and others. Aurobindo’s expanded operations in North Carolina will create a $17.1 million annual payroll impact for Durham and surrounding counties.